{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:39:05Z","timestamp":1772138345698,"version":"3.50.1"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Mandell Braunstein IBD Research Chair"},{"name":"David and Geri Epstein Foundation Fund"},{"name":"Ellen Oland Endowed Fund for Pediatric IBD Research"},{"DOI":"10.13039\/100009929","name":"Achelis and Bodman Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009929","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19 AI142733-01"],"award-info":[{"award-number":["U19 AI142733-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R61HD105613"],"award-info":[{"award-number":["R61HD105613"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Characterization of neutralization antibodies to SARS-CoV-2 infection or vaccination in children and young adults with inflammatory bowel disease (IBD) receiving biologic therapies is crucial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a prospective longitudinal cohort study evaluating SARS-CoV-2 spike protein receptor binding domain (S-RBD) IgG positivity along with consistent clinical symptoms in patients with IBD receiving infliximab or vedolizumab. Serum was also obtained following immunization with approved vaccines. The IgG antibody to the spike protein binding domain of SARS-CoV-2 was assayed with a fluorescent bead-based immunoassay that takes advantage of the high dynamic range of fluorescent molecules using flow cytometry. A sensitive and high-throughput neutralization assay that incorporates SARS-CoV-2 spike protein onto a lentivirus and measures pseudoviral entry into ACE2-angiotensin converting enzyme 2 (ACE2) expressing human embryonic kidney 293 (HEK-293) cells was used.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 436 patients enrolled (mean age, 17 years, range 2\u201326 years; 58% male; 71% Crohn\u2019s disease, 29% ulcerative colitis, IBD-unspecified). Forty-four (10%) of enrolled subjects had SARS-CoV-2 S-RBD IgG antibodies. Compared to non-IBD adults (ambulatory) and hospitalized pediatric patients with PCR documented SARS-CoV-2 infection, S-RBD IgG antibody levels were significantly lower in the IBD cohort and by 6 months post infection most patients lacked neutralizing antibody. Following vaccination (n\u2005=\u200533), patients had a 15-fold higher S-RBD antibody response in comparison with natural infection, and all developed neutralizing antibodies to both wild type and variant SARS-CoV-2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The lower and less durable SARS-CoV-2 S-RBD IgG response to natural infection in IBD patients receiving biologics puts them at risk of reinfection. The robust response to immunization is likely protective.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izab207","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T06:22:37Z","timestamp":1631773357000},"page":"1019-1026","source":"Crossref","is-referenced-by-count":26,"title":["Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"28","author":[{"given":"Joelynn","family":"Dailey","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Connecticut School of Medicine , Farmington, CT , USA"},{"name":"Division of Digestive Diseases, Hepatology, and Nutrition, Connecticut Children\u2019s Medical Center , Hartford, CT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Kozhaya","sequence":"additional","affiliation":[{"name":"Jackson Laboratory for Genomic Medicine , Farmington, CT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikail","family":"Dogan","sequence":"additional","affiliation":[{"name":"Jackson Laboratory for Genomic Medicine , Farmington, CT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dena","family":"Hopkins","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Connecticut School of Medicine , Farmington, CT , USA"},{"name":"Division of Digestive Diseases, Hepatology, and Nutrition, Connecticut Children\u2019s Medical Center , Hartford, CT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blaine","family":"Lapin","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Connecticut Children\u2019s Medical Center , Hartford, CT , USA"},{"name":"Department of Pediatrics, University of Connecticut School of Medicine , Farmington, CT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Herbst","sequence":"additional","affiliation":[{"name":"Division of Research, Connecticut Children\u2019s Medical Center , Hartford, CT , USA"},{"name":"Department of Pediatrics, University of Connecticut School of Medicine , Farmington, CT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Brimacombe","sequence":"additional","affiliation":[{"name":"Division of Research, Connecticut Children\u2019s Medical Center , Hartford, CT , USA"},{"name":"Department of Pediatrics, University of Connecticut School of Medicine , Farmington, CT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Grandonico","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Connecticut School of Medicine , Farmington, CT , USA"},{"name":"Division of Digestive Diseases, Hepatology, and Nutrition, Connecticut Children\u2019s Medical Center , Hartford, CT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Karabacak","sequence":"additional","affiliation":[{"name":"Jackson Laboratory for Genomic Medicine , Farmington, CT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Schreiber","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases and Immunology, Connecticut Children\u2019s Medical Center , Hartford, CT , USA"},{"name":"Department of Pediatrics, University of Connecticut School of Medicine , Farmington, CT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce Tsan-Liang","family":"Liang","sequence":"additional","affiliation":[{"name":"Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine , Farmington, CT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C","family":"Salazar","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases and Immunology, Connecticut Children\u2019s Medical Center , Hartford, CT , USA"},{"name":"Department of Pediatrics, University of Connecticut School of Medicine , Farmington, CT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya","family":"Unutmaz","sequence":"additional","affiliation":[{"name":"Jackson Laboratory for Genomic Medicine , Farmington, CT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9769-236X","authenticated-orcid":false,"given":"Jeffrey S","family":"Hyams","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Connecticut School of Medicine , Farmington, CT , USA"},{"name":"Division of Digestive Diseases, Hepatology, and Nutrition, Connecticut Children\u2019s Medical Center , Hartford, CT , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"key":"2022070108581392100_CIT0001","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2020.05.032","article-title":"Corticosteroids, but not TNF antagonists, are associated with adverse COVID-19 outcomes in patients with inflammatory bowel diseases: results from an international registry","volume":"159","author":"Brenner","year":"2020","journal-title":"Gastroenterology."},{"key":"2022070108581392100_CIT0002","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.cgh.2020.10.010","article-title":"Benign evolution of SARS-Cov2 infections in children with inflammatory bowel disease: results from two international databases","volume":"19","author":"Brenner","year":"2021","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022070108581392100_CIT0003","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.cgh.2020.04.071","article-title":"Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan Cohorts","volume":"18","author":"Allocca","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"key":"2022070108581392100_CIT0004","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/gutjnl-2020-322539","article-title":"Effect of IBD medications on COVID-19 outcomes: results from an international registry","volume":"70","author":"Ungaro","year":"2021","journal-title":"Gut."},{"key":"2022070108581392100_CIT0005","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.chom.2020.04.017","article-title":"Heightened innate immune responses in the respiratory tract of COVID-19 patients","volume":"27","author":"Zhou","year":"2020","journal-title":"Cell Host Microbe."},{"key":"2022070108581392100_CIT0006","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200678","article-title":"The many faces of the anti-COVID immune response","volume":"217","author":"Vardhana","year":"2020","journal-title":"J Exp Med."},{"key":"2022070108581392100_CIT0007","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.chom.2020.05.009","article-title":"The innate immune system: fighting on the front lines or fanning the flames of COVID-19?","volume":"27","author":"McKechnie","year":"2020","journal-title":"Cell Host Microbe."},{"key":"2022070108581392100_CIT0008","first-page":"eabc8511","article-title":"Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions","volume":"369","author":"Mathew","year":"2020","journal-title":"bioRxiv."},{"key":"2022070108581392100_CIT0009","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1038\/s41467-020-18450-4","article-title":"A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease","volume":"11","author":"Huang","year":"2020","journal-title":"Nature Commun"},{"key":"2022070108581392100_CIT0010","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1515\/cclm-2020-0617","article-title":"The early antibody response to SARS-Cov-2 infection","volume":"58","author":"Dittadi","year":"2020","journal-title":"Clin Chem Lab Med."},{"key":"2022070108581392100_CIT0011","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature."},{"key":"2022070108581392100_CIT0012","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41392-020-0191-1","article-title":"Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2","volume":"5","author":"Catanzaro","year":"2020","journal-title":"Signal Transduct Target Ther."},{"key":"2022070108581392100_CIT0013","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gutjnl-2021-324388","article-title":"Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab","volume":"70","author":"Kennedy","year":"2021","journal-title":"Gut."},{"key":"2022070108581392100_CIT0014","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform."},{"key":"2022070108581392100_CIT0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s42003-021-01649-6","article-title":"SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus","volume":"4","author":"Dogan","year":"2021","journal-title":"Commun Biol."},{"key":"2022070108581392100_CIT0016","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jamainternmed.2020.7976","article-title":"Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020","volume":"181","author":"Bajema","year":"2021","journal-title":"JAMA Intern Med."},{"key":"2022070108581392100_CIT0017","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gutjnl-2021-324388","article-title":"Infliximab is associated with attenuated immunogenicity to BNT162b2 and ChAdOx1 nCoV-19 SARS-CoV-2 vaccines in patients with IBD","volume":"70","author":"Kennedy","year":"2021","journal-title":"Gut."},{"key":"2022070108581392100_CIT0018","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/gutjnl-2020-324000","article-title":"SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting","volume":"70","author":"Siegel","year":"2021","journal-title":"Gut."},{"key":"2022070108581392100_CIT0019","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.crohns.2012.05.011","article-title":"Immune response to influenza A\/H1N1 vaccine in inflammatory bowel disease patients treated with anti TNF-\u03b1 agents: effects of combined therapy with immunosuppressants","volume":"7","author":"Andrisani","year":"2013","journal-title":"J Crohns Colitis."},{"key":"2022070108581392100_CIT0020","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/MIB.0000000000000615","article-title":"Immunogenicity of influenza vaccine for patients with inflammatory bowel disease on maintenance infliximab therapy: a randomized trial","volume":"22","author":"deBruyn","year":"2016","journal-title":"Inflamm Bowel Dis."},{"key":"2022070108581392100_CIT0021","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/ibd\/izx001","article-title":"Antibody response to hepatitis B virus vaccine is impaired in patients with inflammatory bowel disease on infliximab therapy","volume":"24","author":"Pratt","year":"2018","journal-title":"Inflamm Bowel Dis."},{"key":"2022070108581392100_CIT0022","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/MPG.0000000000002810","article-title":"Immune response to vaccination in children and young people with inflammatory bowel disease: a systematic review and meta-analysis","volume":"71","author":"Dembi\u0144ski","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"2022070108581392100_CIT0023","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2021-220289","article-title":"Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases","author":"Boyarsky","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"2022070108581392100_CIT0024","first-page":"898","article-title":"Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial","volume":"77","author":"Park","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"2022070108581392100_CIT0025","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2021-220597","article-title":"Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease","author":"Haberman","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"2022070108581392100_CIT0026","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine","volume":"384","author":"Krammer","year":"2021","journal-title":"N Engl J Med."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/28\/7\/1019\/44267964\/izab207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/28\/7\/1019\/44267964\/izab207.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T05:03:08Z","timestamp":1656651788000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/28\/7\/1019\/6371006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,9,16]]},"published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izab207","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.12.21258810","asserted-by":"object"}]},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2021,9,16]]}}}